Recent studies have shown that the inhibition of KIF18A expression in HCC could reduce cell cycle-related protein expression levels, and KIF18A might promote HCC cell proliferation through the cell cycle signaling pathway [13]. Here, KIF18A is linked to hepatocellular carcinoma.